Quantbot Technologies LP Krystal Biotech, Inc. Transaction History

Quantbot Technologies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$108.01 - $179.35 $14,797 - $24,570	137 New	137 $24,000
Q4 2021 Feb 11, 2022	SELL	$39.81 - $88.24 $3,981 - $8,824	-100 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$52.01 - $71.77 $5,201 - $7,177	-100 Reduced 50.0%	100 $5,000
Q2 2021 Aug 12, 2021	BUY	$62.14 - $81.82 $12,428 - $16,363	200 New	200 $13,000

304

24.3M

483K

364K

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.08B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.